Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: A consensus conference report

Diabetes Research and Clinical Practice

Volumn 45, Issue 1, 1999, Pages 61-73

  Moran, A ^a   Hardin, D ^a   Rodman, D ^a   Allen, H F ^a   Beall, R J ^a   Borowitz, D ^a   Brunzell, C ^a   Campbell, P W ^a   Chesrown, S E ^a   Duchow, C ^a   Fink, R J ^a   Fitzsimmons, S C ^a   Hamilton, N ^a   Hirsch, I ^a   Howenstine, M S ^a   Klein, D J ^a   Madhun, Z ^a   Pencharz, P B ^a   Quittner, A L ^a   Robbins, M K ^a   Schindler, T ^a   Schissel, K ^a   Schwarzenberg, S J ^a   Stallings, V A ^a   Tullis, D E ^a   Zipf, W B ^a   more..

^a NONE

Author keywords

Cystic fibrosis; Cystic fibrosis related diabetes mellitus; Diabetes mellitus

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

CONFERENCE PAPER; CYSTIC FIBROSIS; DIABETES MELLITUS; DIET; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MORTALITY; NUTRITION; ORAL GLUCOSE TOLERANCE TEST; PATIENT COMPLIANCE; PREGNANCY;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIET THERAPY; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY IN DIABETICS;

EID: 0032783588     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00058-3     Document Type: Conference Paper

References (60)

1. FitzSimmons S. The changing epidemiology of cystic fibrosis. J. Pediatr. 122:1993;1-9.
2. Cystic Fibrosis Foundation Patient Registry, 1997 Annual Data Report, Bethesda, MD, 1998.
3. Rosenecker J., Eichler I., Kuhn L., Harms H.K., von der Hardt J. Genetic determination of diabetes mellitus in patients with cystic fibrosis. J. Pediatr. 127:1995;441-443.
4. Lanng S., Thorsteinsson B., Lund-Andersen C., Nerup J., Schiotz P.O., Koch C. Diabetes mellitus in Danish CF patients: prevalence and late diabetic complications. Acta Paediatr. 83:1994;72-77.
5. Moran A., Doherty L., Wang X., Thomas W. Abnormal glucose metabolism in cystic fibrosis. J. Pediatr. 133:1998;10-16.
6. Finkelstein S.M., Wielinski C.L., Elliott G.R., Warwick W.J., Barbosa J., Wu S.C., Klein D.J. Diabetes mellitus associated with cystic fibrosis. J. Pediatr. 112:1988;373-377.
7. Lanng S., Thorsteinsson B., Nerup J., Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr. 83:1994;849-853.
8. Lanng S., Thorsteinsson B., Nerup J., Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur. J. Pediatr. 151:1992;684-687.
9. Miller M., Ward L., Thomas B.J., Cooksley W.G.E., Shepherd R.W. Altered body composition and muscle protein degradation in nutritionally growth-retarded children with cystic fibrosis. Am. J. Clin. Nutr. 36:1982;492-499.
10. Steinkamp G., von der Hardt H. Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis. J. Pediatr. 124:1994;244-249.
11. Hardin D.S., Leblanc A., Lukenbaugh S., Para L., Seilheimer D.K. Proteolysis associated with insulin resistance in cystic fibrosis. Pediatrics. 101:1998;433-437.
12. Sandler M. Is the lung a 'target organ' in diabetes mellitus? Arch. Intern. Med. 150:1988;1385-1388.
13. Niranjan V., McBrayer D.G., Ramirez L.C., Raskin P., Hsia C.C.W. Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus. Am. J. Med. 103:1997;504-513.
14. Geffner M.E., Lippe B.M., Maclaren N.K., Riley W.J. Role of autoimmunity in insulinopenia and carbohydrate derangements with cystic fibrosis. J. Pediatr. 112:1988;419-421.
15. De Luca F., Arrigo T., Conti Nibali S., Sferlazzas C., Gigante A., DiCesare E., Cucinotta D. Insulin secretion, glycosylated haemoglobin and islet cell antibodies in cystic fibrosis children and adolescents with different degrees of glucose tolerance. Horm. Metab. Res. 23:1991;495-498.
16. Lanng S., Thorsteinsson B., Pociot F., Marshall M.O., Madsen H.O., Schwartz M., Nerup J., Koch C. Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Paediatr. 82:1993;150-154.
17. Stewart A.K., Hanna M., Corey J., Zielenski J., Tsui L.-C., Durie P.B., Pencharz P.B., Tullis E. Glucose tolerance in adults with CF: phenotype-genotype correlations. Pediatr. Pulmonol. Suppl. 14:1997;361A.
18. Sullivan M.M., Denning C.R. Diabetic microangiopathy in patients with cystic fibrosis. Pediatrics. 84:1989;642-646.
19. Rodman H.M., Doershuk C.F., Roland J.M. The interaction of two diseases: diabetes mellitus and cystic fibrosis. Medicine. 65:1986;389-397.
20. Stewart C., Wilson D.C., Hanna A.K., Corey M., Durie P.R., Pencharz P.B. Lipid metabolism in adults with CF. Pediatr. Pulmonol. Suppl. 14:1997;366A.
21. Schlesinger D.M., Holsclw D.S., Fyfe B. Generalized atherosclerosis in an adult with CF and diabetes mellitus. Pediatr. Pulmonol. Suppl. 14:1997;365A.
22. Moran A., Diem P., Klein D.J., Levitt M.D., Robertson R.P. Pancreatic endocrine function in cystic fibrosis. J. Pediatr. 118:1991;715-723.
23. Lippe B.M., Sperling M.A., Dooley R.R. Pancreatic alpha and beta cell function in cystic fibrosis. J. Pediatr. 90:1977;751-755.
24. Lanng S., Thorsteinsson B., Roder M.E., Orskov C., Holst J., Nerup J., Koch C. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol. 128:1993;207-214.
25. Cucinotta D., Conti Nibali S., Arrigo T., Di Benedetto A., Magazzu G., Di Cesare E., Constantino A. Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance. Horm. Res. 34:1990;33-38.
26. DeSchepper J., Hachimi-Idrissi S., Smitz J., Dab I., Loeb H. First-phase insulin release in adult cystic fibrosis patients: correlation with clinical and biological parameters. Horm. Res. 38:1992;260-263.
27. Meacham L.R., McKean L.P., Buchanan C.N., Caplan D.B., Pfaffle R.W., Parks J.S., Culler F.L. Selective preservation of somatostatin secretion in CF patients with diabetes. Pediatr. Pulmonol. Suppl. 6:1991;333A.
28. Lohr M., Goertchem P., Nizze H., Gould N.S., Gould V.E., Oberholzer M., Heitz P.U., Kloppel G. CF associated islet changes may provide a basis for diabetes. Virchows Arch. A Pathol. Anat. 414:1989;179-185.
29. Kopito L.E., Schwachman H. The pancreas in CF: chemical composition and comparative morphology. Pediatr. Res. 10:1976;742-749.
30. Iannucci A., Mukai K., Johnson D., Burke B. Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum. Pathol. 15:1984;278-284.
31. Couce M., O'Brien T.D., Moran A., Roche P.C., Butler P.C. Diabetes mellitus in CF is characterized by islet amyloidosis. J. Clin. Endocrinol. Metab. 81:1996;1267-1272.
32. Johnson K.H., O'Brien T.D., Betsholtz C., Westermark P. Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus. New Engl. J. Med. 321:1989;513-518.
33. Laszik Z., Pap A., Farkas G., Ormos J. Endocrine pancreas in chronic pancreatitis. Arch. Pathol. Lab. Med. 113:1989;47-51.
34. Clark A., Cooper G.J.S., Lewis C.E., Morris J.F., Willis A.C., Reid K.B.M., Turner R.C. Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet. 2:1987;231-234.
35. Lorenzo A., Razzaboni B., Weir G.C., Yankner B.A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature. 368:1994;756-760.
36. Moran A., Pyzdrowski K., Weinreb M.D., Kahn B.B., Smith S.A., Adams K.L., Seaquist E.R. Insulin sensitivity in cystic fibrosis. Diabetes. 43:1994;1020-1026.
37. Holl R.W., Heinze E., Wolf A., Rank M., Teller W.M. Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycemia in CF. Eur. J. Pediatr. 154:1995;356-361.
38. Austin A., Kalhan S.C., Orenstein D., Nixon P. Roles of insulin resistance and β-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. J. Clin. Endocrinol. Metab. 79:1994;80-85.
39. Hardin D.S., LeBlanc A., Lukenbaugh S., Seilheimer D.K. Insulin resistance is associated with decreased clinical status in cystic fibrosis. J. Pediatr. 130:1997;948-956.
40. Lanng S., Thorsteinsson B., Roder M.E., Nerup J., Koch C. Insulin sensitivity and insulin clearance in CF patients with normal and diabetic glucose tolerance. Clin. Endocrinol. 41:1994;217-223.
41. Ahmad T., Nelson R., Taylor R. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis. Metabolism. 43:1994;163-167.
42. Clinical practice recommendations. Diabetes Care. S1:1998.
43. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 20:1997;1183-1197.
44. Allen H., Klingensmith G.J., Gay E., Hamman R. Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the U.S. Diabetes Care. 21:1998;943-948.
45. McCance D.R., Hanson R., Charles M.A., Jacobsson L.T.H., Pettitt D.J., Bennett P.H., Knowler W.C. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. Br. Med. J. 308:1994;1323-1328.
46. Engelgau M.M., Thompson T.J., Herman W.H., Boyle J.P., Aubert R.E., Kenny S.J., Badran A., Sous E.S., Ali M.A. Comparison of fasting and 2-hour glucose and hemoglobin A1c levels for diagnosing diabetes: diagnostic criteria and performance revisited. Diabetes Care. 20:1997;785-791.
47. Lanng S., Hansen A., Thorsteinsson B., Nerup J., Koch C. Glucose tolerance in cystic fibrosis: a five year prospective study. Br. Med. J. 311:1995;655-6659.
48. DeSchepper J., Dab I., Derde M.P., Loeb H. Oral glucose tolerance testing in cystic fibrosis: correlations with clinical parameters and glycosylated hemoglobin determinations. Eur. J. Pediatr. 150:1991;403-406.
49. De Luca F., Arrigo T., De Benedetto A., Tedeschi A., Sferlazzas C., Crisafulli G., Di Cesare E., Romano F., Magazzu G., Cucinotta D. Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic CF patients. Horm. Res. 44:1995;45-50.
50. Bertele-Harms R.M., Harms H.K. Sulfonylurea in the treatment of CFRD. A 15 year experience. Pediatr. Pulmonol. 13:1996;380A.
51. Culler, F.L., McKean, L.P., Buchanan, C.J., Caplan, D.B., Meacham, L.R., Glipizide treatment of patients with CF and impaired glucose tolerance, Endocrine Society Program and Abstracts, San Antonio, TX, 1992, 45A.
52. Hinds A., Sheehan A.G., Parsons H.G. Tobutamide causes a modest increase in insulin secretion in CF patients with impaired glucose tolerance. Metab. Clin. Exp. 44:1995;13-18.
53. Horswill C.A., Zipf W.B., Kien C.L., McCoy K.S., O'Dorisio T. Glipizide increased insulin secretion but not growth of children with CF. FASEB J. 4:1990;3272A.
54. Zipf W.B., Kien C.L., Horswill C.A., McCoy K.S., O'Dorisio T., Pinyerd B.L. Effects of tolbutamide on growth and body composition of nondiabetic children with CF. Pediatr. Res. 30:1991;309-314.
55. + channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents. J. Gen. Physiol. 100:1992;573-591.
56. Ramsey B.W., Farrell P., Pencharz P.B. Nutritional assessment and management in cystic fibrosis: a consensus report. Am. J. Clin. Nutr. 55:1992;71-75.
57. Kraemer R., Rudeberg A., Hadorn B., Rossi E. Relative underweight in cystic fibrosis and its prognostic value. Acta Paediatr. Scand. 67:1978;33-37.
58. FitzSimmons S.C., Fitzpatrick S., Thompson B., Aitkin M., Fiel S., Winnie G., Hilman B. A longitudinal sudy of the effects of pregnancy on 325 women with CF. Pediatr. Pulmonol. 13:1996;99-101.
59. La Greca A.M., Schuman W.B. Adherence to prescribed medical regiments. Roberts M.C. Handbook of Pediatric Psychology. 2nd ed. 1995;55-83 Guilford Press, New York.
60. Johnson S.B. Insulin-dependent diabetes mellitus in childhood. Roberts M.C. Handbook of Pediatric Psychology. 2nd ed. 1995;263-285 Guilford Press, New York.